SCHEMBL25258582

SCHEMBL25258582

COc1cccc(CN(Cc2ccc(N3CCN(C)CC3)cc2)c2ccc(COCCN3CCOCC3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.46
▸ DRD4 P21917 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ ABCB1 P08183 7/20 0.43
▸ ROCK2 O75116 2/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ LTA4H P09960 1/20 0.40
▸ VNN1 O95497 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30245231 1.00 DRD2 (0.46) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL25298289 0.98 DRD2 (0.44) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL30245483 0.98 DRD2 (0.44) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL30245058 0.96 ALDH1A1 (0.47) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL30245454 0.96 KCNH2 (0.46) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL25294506 0.96 KCNH2 (0.46) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL25261051 0.95 ALDH1A1 (0.45) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL30245846 0.95 ALDH1A1 (0.45) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL30245107 0.95 ALDH1A1 (0.45) DRD2DRD4ALDH1A1TSHRSMN1; SMN2
SCHEMBL25298177 0.94 KCNH2 (0.44) DRD2DRD4ALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO disclosed
Send feedback